Serum Institute seeks drug regulator's approval for market authorisation of Covovax as booster dose
India | December 25, 2022 13:54 ISTCovid-19: Earlier on October 17, Prakash Kumar Singh, director of government and regulatory affairs at SII, submitted a market authorization application to the Drug Controller General of India (DCGI) for the heterologous booster dose of Covovax.